More on BLTE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-182.1% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Belite Bio (NQ:BLTE)
Delayed: 156.70 +0.99 (0.64%)
Prev. Close $155.71  
Open$154.49 
52 Wk High$ 
52 Wk Low$ 
Day High$157.19 
Day Low$153.85 
P/E N/A  
EPS$ 
Volume114,136 

Friends, Peers and Foes (?): LOT, VIOT, YRD, FPAFY, FPC (more...)

Sep 1, 2026 08:00 AM Belite Bio to Participate in Four Upcoming Investor Conferences
Aug 24, 2026 04:00 PM Belite Bio to Host Virtual Commercial Day on September 2, 2026
Aug 21, 2026 08:00 AM Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
Aug 17, 2026 08:58 AM Belite Bio, Inc, ADR (BLTE) PT Raised to $206 at Morgan Stanley
Aug 14, 2026 08:35 AM Belite Bio, Inc, ADR (BLTE) PT Raised to $206 at Morgan Stanley
Aug 14, 2026 07:54 AM Belite Bio (BLTE) Reiterated at Buy by Benchmark on Tinlarebant NDA Acceptance by FDA
Aug 14, 2026 06:37 AM Belite Bio, Inc, ADR (BLTE) PT Raised to $220 at Mizuho
Aug 14, 2026 06:14 AM Form 4 BELITE BIO, INC For: Aug 12 Filed by: Lin Yu-Hsin
Aug 14, 2026 06:14 AM Form 4 BELITE BIO, INC For: Aug 12 Filed by: Chuang Hao-Yuan
Aug 13, 2026 06:06 AM Form 6-K BELITE BIO, INC For: Aug 12
View All Articles

Entities mentioned with BLTE

View All Entities